Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tg Therapeutics (TGTX) Other Operating Expenses: 2010-2024

Historic Other Operating Expenses for Tg Therapeutics (TGTX) over the last 15 years, with Dec 2024 value amounting to $38.5 million.

  • Tg Therapeutics' Other Operating Expenses rose 200.75% to $28.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.0 million, marking a year-over-year increase of 152.01%. This contributed to the annual value of $38.5 million for FY2024, which is 172.35% up from last year.
  • Per Tg Therapeutics' latest filing, its Other Operating Expenses stood at $38.5 million for FY2024, which was up 172.35% from $14.1 million recorded in FY2023.
  • In the past 5 years, Tg Therapeutics' Other Operating Expenses registered a high of $38.5 million during FY2024, and its lowest value of -$41.5 million during FY2020.
  • Its 3-year average for Other Operating Expenses is $17.6 million, with a median of $14.1 million in 2023.
  • Per our database at Business Quant, Tg Therapeutics' Other Operating Expenses plummeted by 336.90% in 2020 and then skyrocketed by 5,232.45% in 2023.
  • Tg Therapeutics' Other Operating Expenses (Yearly) stood at -$41.5 million in 2020, then surged by 101.90% to $790,000 in 2021, then plummeted by 66.46% to $265,000 in 2022, then spiked by 5,232.45% to $14.1 million in 2023, then soared by 172.35% to $38.5 million in 2024.